K203129 is an FDA 510(k) clearance for the NexGen Standalone Anterior Cervical Discectomy and Fusion (ACDF) System. Classified as Intervertebral Fusion Device With Integrated Fixation, Cervical (product code OVE), Class II - Special Controls.
Submitted by Precision Spine, Inc. (Pear, US). The FDA issued a Cleared decision on January 12, 2021 after a review of 85 days - a notably fast clearance cycle.
This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Precision Spine, Inc. devices